Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Goodman

Showing results (451-460 of 582) with videos related to

Pageof 59
Sort By:
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Polymorphisms in inflammation pathway genes and endometrial cancer riskRyan J Delahanty, Yong-Bing Xiang, Amanda Spurdle, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
American Journal of Epidemiology|July 27, 2012
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortiumVeronica Wendy Setiawan, Malcolm C Pike, Stalo Karageorgi, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Journal of the National Cancer Institute|January 23, 2023
Risk prediction models for endometrial cancer: development and validation in an international consortiumJoy Shi, Peter Kraft, Bernard A Rosner, et al.
American Journal of Epidemiology|October 5, 2016
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic LociMerlise A Clyde, Rachel Palmieri Weber, Edwin S Iversen, et al.
Pageof 59

Showing results (451-460 of 582) with videos related to

Sort By:
Pageof 59
International Journal of Epidemiology|April 10, 2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studiesWeiva Sieh, Shannon Salvador, Valerie McGuire, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Polymorphisms in inflammation pathway genes and endometrial cancer riskRyan J Delahanty, Yong-Bing Xiang, Amanda Spurdle, et al.
Gynecologic Oncology|March 19, 2023
Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysisTheodore M Brasky, Erinn M Hade, David E Cohn, et al.
American Journal of Epidemiology|July 27, 2012
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortiumVeronica Wendy Setiawan, Malcolm C Pike, Stalo Karageorgi, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Journal of the National Cancer Institute|January 23, 2023
Risk prediction models for endometrial cancer: development and validation in an international consortiumJoy Shi, Peter Kraft, Bernard A Rosner, et al.
American Journal of Epidemiology|October 5, 2016
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic LociMerlise A Clyde, Rachel Palmieri Weber, Edwin S Iversen, et al.
Pageof 59